The promise of omega-3 against sudden unexpected death in epilepsy: Until further notice, it remains innocent, until proven guilty;Promessa do ômega-3 contra a morte súbita em epilepsia: Até segunda ordem, continua inocente, até que se prove o contrário

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 1, 2013, Pages 51-54

  Scorza, Fulvio Alexandre ^a   Lopes, Antonio Carlos ^a   Cysneiros, Roberta Monterazzo ^b   Arida, Ricardo Mario ^a   e Silva, Maurício Rocha ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epilepsy; Omega 3; Seizures; SUDEP

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; LINOLENIC ACID; OMEGA 3 FATTY ACID; PHENOBARBITAL; POTASSIUM BROMIDE;

ANTICONVULSANT ACTIVITY; DIET SUPPLEMENTATION; EPILEPSY; FEBRILE CONVULSION; FISH; FOOD INTAKE; HEART RATE; HUMAN; NEUROPROTECTION; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; SUDDEN DEATH;

EID: 84872976823     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2012005000014     Document Type: Review

References (38)

1. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16:165-710.
2. de Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav 2008;12:540-546.
3. Nashef L, Ryvlin P. Sudden unexpected death in epilepsy (SUDEP): update and reflections. Neurol Clin 2009;27:1063-1074.
4. Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet 2006;367:1087-1100.
5. Nei M, Hays R. Sudden unexpected death in epilepsy. Curr Neurol Neurosci Rep 2010;10:319-326.
6. Surges R, Sander JW. Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. Curr Opin Neurol 2012;25:201-207.
7. Schuele SU, Widdess-Walsh P, Bermeo A, Lüders HO. Sudden unexplained death in epilepsy: the role of the heart. Cleve Clin J Med 2007;74(Suppl):S121-S127.
8. Hesdorffer DC, Tomson T, Benn E, et al. ILAE Commission on Epidemiology; Subcommission on Mortality. Combined analysis of risk factors for SUDEP. Epilepsia 2011;52:1150-1159.
9. Surges R, Thijs RD, Tan HL, Sander JW. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat Rev Neurol 2009;5:492-504.
10. Tomson T, Nashef L, Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol 2008;7:1021-1031.
11. Stollberger C, Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 2004;59:51-60.
12. Surges R, Taggart P, Sander JW, Walker MC. Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death. Epilepsia 2010;51:738-744.
13. Nei M, Ho RT, Abou-Khalil BW, et al. EEG and ECG in sudden unexplained death in epilepsy. Epilepsia 2004;45:338-345.
14. Scorza FA, Colugnati DB, Pansani AP, Sonoda EY, Arida RM, Cavalheiro EA. Preventing tomorrow's sudden cardiac death in epilepsy today: what should physicians know about this? Clinics 2008;63:389-394.
15. Scorza FA, Arida RM, Terra VC, Cavalheiro EA. What can be done to reduce the risk of SUDEP? Epilepsy Behav 2010;18:137-138.
16. Taha AY, Burnham WM, Auvin S. Polyunsaturated fatty acids and epilepsy. Epilepsia 2010;51:1348-1358.
17. Ohara K. The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:469-474.
18. Calon F, Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 2007;77:287-293.
19. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 2004;8:163-174.
20. Spirer Z, Koren L, Finkelstein A, Jurgenson U. Prevention of febrile seizures by dietary supplementation with N-3 polyunsaturated fatty acids. Med Hypotheses 1994;43:43-45.
21. Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994;254:193-198.
22. Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998;341:145-152.
23. Xiao Y, Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 1999;846:112-121.
24. Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002;43:103-104.
25. Yuen AW, Sander JW, Fluegel D, et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 2005;7:253-258.
26. Ferrari D, Cysneiros RM, Scorza CA, et al. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav 2008;13:36.
27. Cysneiros RM, Ferrari D, Arida RM, et al. Qualitative analysis of hippocampal plastic changes in rats with epilepsy supplemented with oral omega-3 fatty acids. Epilepsy Behav 2010;17:33-38.
28. Taha AY, Filo E, Ma DW, McIntyre Burnham W. Dose-dependent anticonvulsant effects of linoleic and alpha-linolenic polyunsaturated fatty acids on pentylenetetrazol induced seizures in rats. Epilepsia 2009;50:72-82.
29. Scorza FA, Cavalheiro EA, Arida RM, et al. Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study. Epilepsy Behav 2009;15:527-528.
30. Yuen AW, Flugel D, Poepel A, Bell GS, Peacock JL, Sander JW. Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy. Epilepsy Behav 2012;23:370-372.
31. DeGiorgio CM, Miller P. n-3 fatty acids (eicosapentanoic and docosahexanoic acids) in epilepsy and for the prevention of sudden unexpected death in epilepsy. Epilepsy Behav 2008;13:712-713.
32. He K. Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease eat fish or take fish oil supplement? Prog Cardiovasc Dis 2009;52:95-114.
33. Smith KM, Sahyoun NR. Fish consumption: recommendations versus advisories, can they be reconciled? Nutr Rev 2005;63:39-46.
34. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004;107:1-11.
35. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011;58:2047-2067.
36. Yuen AW, Sander JW. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 2004;13:104-107.
37. Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, Albuquerque M, Cavalheiro EA. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav 2008;13:279-283.
38. Colugnati DB, Gomes PA, Arida RM, et al. Analysis of cardiac parameters in animals with epilepsy: possible cause of sudden death? Arq Neuropsiquiatr 2005;63:1035-1041.